Jennifer Presthus Lukaska is the Founder and CEO of Waypoint Clinical, which she established in 2018. Prior to founding Waypoint, Jennifer spent more than 20 years working as both an employee and independent contractor in clinical research. Her hands-on experience includes involvement in dozens of clinical studies across both medical device and pharmaceutical development, as well as personally speaking with more than 10,000 patients to assess study eligibility. This work has resulted in a deep understanding of patient recruitment challenges and a strong industry network spanning early-stage startups to publicly traded organizations.

Jennifer's passion for clinical research is rooted in working with patients and clients who are each searching for a path forward. She is deeply committed to a patient-centered approach to recruitment and study execution, helping ensure new therapies are brought to market thoughtfully, efficiently, and with the patient experience at the forefront.

In 2026, Waypoint Clinical expanded its capabilities to include the full-service patient recruitment methodology established by Galen Patient Recruitment over nearly two decades. Having partnered closely with Galen Patient Recruitment for years, providing pre-screening and site support services for Galen’s clients, Jennifer brings both familiarity with the methodology and trusted relationships with the sponsors and sites it has served. She is honored to build on that foundation, combining Galen’s proven recruitment framework with Waypoint’s screening expertise to deliver a seamless, end-to-end approach. Her commitment is not only to carry that legacy forward, but to continue advancing how recruitment and screening services are delivered, with the patient experience at the forefront.